lanreotide
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INJECTION, SUBCUTANEOUS | 60 mg/0.2 mL; 90 mg/0.3 mL | Formulary restricted to outpatient | ||||||||||
| SOLUTION, SUBCUTANEOUS | 90 mg/0.3 mL; 120 mg/0.5 mL | Formulary restricted to outpatient |